Peter P. Pfreundschuh's Net Worth

$2.09 Million

Estimate Recalculated Jul 8, 2024 07:00PM EST

Who is Peter P. Pfreundschuh?

Peter P. Pfreundschuh has an estimated net worth of $2.09 Million. This is based on reported shares across multiple companies, which include IMMUNOMEDICS INC, Sucampo Pharmaceuticals, Inc., UroGen Pharma Ltd., Frequency Therapeutics, Inc., and Voyager Therapeutics, Inc..

SEC CIK

Peter P. Pfreundschuh's CIK is 0001585839

Past Insider Trading and Trends

2020 was Peter P. Pfreundschuh's most active year for acquiring shares with 10 total transactions. Peter P. Pfreundschuh's most active month to acquire stocks was the month of December. 2020 was Peter P. Pfreundschuh's most active year for disposing of shares, totalling 18 transactions. Peter P. Pfreundschuh's most active month to dispose stocks was the month of January. 2017 saw Peter P. Pfreundschuh paying a total of $3,585.40 for 150,394 shares, this is the most they've acquired in one year. In 2018 Peter P. Pfreundschuh cashed out on 150,263 shares for a total of $1,069,734.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMMUNOMEDICS INC No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+106.79%
15.34K
—
—
29.71K
Aug 20
Form 4
—
0
—
—
0
Mar 9
Form 4
∞
15.81K
—
—
15.81K
Aug 14
Form 4
—
0
—
—
0
Sep 3
Form 3
—
0
—
—
0
No matching records found

Sucampo Pharmaceuticals, Inc. No price found

CFO

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-263.00
$18.00
-$4,734.00
0
Feb 13
Form 4
∞
394
$9.10
$3,585.40
394
Sep 30 - Dec 31
Form 4
—
0
—
—
0
Mar 20
Form 3
—
0
—
—
0
No matching records found

UroGen Pharma Ltd. (URGN) Snapshot price: $15.885

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+31.91%
2.52K
$21.77
-$52,247.75
10.4K
Oct 15
Form 4
+7.25%
533
$22.82
-$11,615.38
7.89K
Sep 1
Form 4
+3.90%
276
$23.51
-$3,314.91
7.36K
Jul 26 - Jul 27
Form 4
+10.68%
683
$25.07
-$8,975.06
7.08K
May 20
Form 4
+4.51%
276
$24.35
-$3,433.35
6.4K
Apr 26 - Apr 27
Form 4
+12.54%
682
$29.68
-$10,684.80
6.12K
Feb 20
Form 4
—
0
—
—
0
Jan 31
Form 4
+29.05%
1K
$29.28
-$19,529.76
4.44K
Jan 26 - Jan 27
Form 4
+25.01%
688
$28.41
-$10,057.14
3.44K
Nov 20
Form 4
∞
2.75K
$33.07
-$46,827.12
2.75K
Aug 20
Form 4
—
0
—
—
0
Jan 26
Form 3
—
0
—
—
0
No matching records found

Frequency Therapeutics, Inc. (KRRO) Snapshot price: $59.57

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-24.81%
-2.95K
$3.69
-$10,885.03
8.93K
Feb 18 - Feb 22
Form 4
-17.54%
-2.52K
$4.31
-$10,886.44
11.87K
Feb 16 - Feb 17
Form 4
+1,832.62%
13.65K
$4.33
-$5,833.86
14.4K
Feb 14 - Feb 15
Form 4
—
0
—
—
0
Apr 20
Form 4
—
0
—
—
0
Jan 15
Form 4
—
0
—
—
0
Dec 2
Form 3
—
0
—
—
0
No matching records found

Voyager Therapeutics, Inc. (VYGR) Snapshot price: $7.37

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-2.10%
-3.76K
$7.46
-$28,079.44
175.67K
Feb 21
Form 4
+20.08%
30K
—
—
179.43K
Feb 9
Form 4
-8.32%
-13.57K
$6.99
-$94,833.33
149.43K
Oct 3
Form 4
+30.40%
38K
—
—
163K
Feb 17
Form 4
∞
125K
—
—
125K
Oct 1
Form 4
—
0
—
—
0
Sep 19
Form 3
—
0
—
—
0
No matching records found